SAN DIEGO, Calif. - Given to celebrate the best practices among healthcare workers, the Health Care Service Excellence Summit Awards were recently announced.
The third annual award winners include:
Health Care Professionals -- Mary Gainey, Health-First/Cape Canaveral Hospital
Dedicated Volunteer - Mary Webster, Tri-City Medical Center
Exceptional Nurse - Patrice Stephens, RN, MS, Advocate Christ Medical Center
Empowering Manager - Eugene Richie, May Clinic Jacksonville
Customer Focused Physician - Kevin Choy, MD, Pacific Alliance Medical Center
Founder's Award - Alice Johnson, Hoag Memorial Hospital Presbyterian
Inspiring Administrator - Phyllis Van Crombrugge, Pacific Alliance Medical Center
Community Relationship Improvement Program - Sheila Brune, Great River Medical Center
Innovative Service Excellence Project - Tri-City Medical Center
Front Line Customer Service Trainer - Judith Campos, Pacific Alliance Medical Center
Front Line Customer Service Training Team - Fab Four, Tri-City Medical Center
Front Line Customer Service Trainer (third year) - John Hirsch, Hoag Memorial Hospital Presbyterian
Service Excellence Program Director - Loren Pop, Tri-City Medical Center
Service Leadership Team - Tri-City Medical Center
Service Recovery Program - six Star Plan, Tri-City Medical Center.
Health at Risk: The Impact of Antimicrobial Resistance From a Global to Local Health Perspective
March 6th 2024Discover the critical role infection preventionists play in combating multidrug-resistant organisms, from the impact on patient care to the challenges of treatment, and the evolving landscape of antimicrobial resistance with Katharine J Hoffman, MPH, CIC.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
FDA Approves Enmetazobactam for Complicated UTIs: A Breakthrough in Antimicrobial Therapy
February 26th 2024Enmetazobactam (Exblifep; Orchid Pharma) has received FDA approval for treating complicated urinary tract infections (cUTIs), offering a promising solution in the battle against antimicrobial resistance.